Back to Topics Listing
May 4, 2016
Füessl HS, Stiefelhagen P
May 3, 2016
Kossoff EH
May 3, 2016
Libbey JE, Doty DJ, Sim JT, Cusick MF, Round JL, Fujinami RS
OBJECTIVE: Many things can impact the reproducibility of results from laboratory to laboratory. For example, food from various sources can vary markedly in composition. We examined the effects of two different food sou...
Apr 30, 2016
Felton EA, Cervenka MC
Ketogenic diet therapies for epilepsy have been described since the fifth century and published in scientific literature since the early 1900s. Since that time, the diet's popularity has waxed and waned as newer drugs ...
Apr 30, 2016
Vaccarezza MM, Silva WH
The ketogenic diet (KD) is currently a well-established treatment for patients with medically refractory, nonsurgical epilepsy. However, despite its efficacy, the KD is highly restrictive and constitutes a treatment wi...
Apr 30, 2016
Kossoff EH, Al-Macki N, Cervenka MC, Kim HD, Liao J, Megaw K, Nathan JK, Raimann X, Rivera R, Wiemer-Kruel A, Williams E, Zupec-Kania BA
Despite the increasing use of dietary therapies for children and adults with refractory epilepsy, the availability of these treatments in developing countries with limited resources remains suboptimal. One possible con...
Apr 28, 2016
Spilioti M, Pavlou E, Gogou M, Katsanika I, Papadopoulou-Alataki E, Grafakou O, Gkampeta A, Dinopoulos A, Evangeliou A
INTRODUCTION: Although ketogenic diet has been proven useful in the management of intractable seizures, interactions with other medicines have been reported. This study reports two patients on co-administration with ke...
Apr 28, 2016
Al-Shamsi A, Baker A, Dhawan A, Hertecant J
Maple syrup urine disease (MSUD) is an autosomal recessive disorder associated with impaired metabolism of branched-chain amino acids (BCAA) leucine, isoleucine, and valine. Children with MSUD suffer from bouts of meta...
Apr 27, 2016
Scichilone JM, Yarraguntla K, Charalambides A, Harney JP, Butler D
For decades, the ketogenic diet has been an effective treatment of intractable epilepsy in children. Childhood epilepsy is pharmacoresistant in 25-40 % of patients taking the current prescribed medications. Chronic sei...
Apr 26, 2016
Szaflarska-Popławska A, Soroczyńska-Wrzyszcz A, Barg E, Józefczuk J, Korczowski B, Grzybowska-Chlebowczyk U, Więcek S, Cukrowska B
INTRODUCTION: The results of studies assessing whether patients with Down syndrome have increased risk of coeliac disease are contradictory. The prevalence of coeliac disease in patients with Down syndrome is estimated...

Pages